LSBio The Immunohistochemistry Antibody Company
  • Home
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
    • IHC-plus Antibodies
    • Isotype Control Antibodies
  • ELISA Kits
    • All Kits
    • Sandwich ELISA Kits
    • EIA Kits
    • Cell-Based ELISA Kits
    • Dna-Binding ELISA Kits
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Anti-PSEN1 / Presenilin 1 Antibody (C-Terminus, PE) LS-C281156

Ordering

Wt. Vol. Conc. Price
- 200 µl - $515

LSBio (Direct) LSBio (Direct)
206-374-1102
866-206-6909
Orders@LSBio.com
 

100% Guaranteed 100% Guaranteed
Rabbit Polyclonal (IgG) to Human PSEN1 / Presenilin 1
Human, Mouse
IHC, Western blot, ELISA
PE Conjugated

Details

Human PSEN1 / Presenilin 1
Rabbit
Human, Mouse (tested or 100% immunogen sequence identity)
IgG Polyclonal
Phycoerythrin (PE)
Affinity purified

Applications

IHC, Western blot, ELISA

Specificity and Use

PSEN1 / Presenilin 1 antibody was raised against kLH-conjugated synthetic peptide from the C-terminus of human PSEN1.
C-Terminus
Human PSEN1 / Presenilin 1
The applications listed above are for the unconjugated form of this antibody. The conjugated antibody has not been tested.

Packaging

PBS, pH 7.2, 0.09% sodium azide.
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 6 months.
For research use only.

About PSEN1 / Presenilin 1

P49768 NM_000021 NP_000012.1

PSEN1 Antibody, AD3 Antibody, Alzheimer disease 3 Antibody, FAD Antibody, Protein S182 Antibody, PS1 Antibody, S182 Antibody, PS-1 Antibody, PSNL1 Antibody, Presenilin 1 Antibody, Presenilin-1 Antibody

Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP.

Requested From: United States
Date Requested: 9/23/2014

Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn
Copyright © 2014 LifeSpan BioSciences, Inc. All Rights Reserved